ArticleBioMed research international2025
Seroprevalence of Hepatitis B Virus Carriage Markers Among Students at the University of Yaoundé II, Cameroon.
Article in BioMed research international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Seroprevalence of Hepatitis B Virus Carriage Markers Among Students at the University of Yaoundé II, Cameroon.BioMed research international · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and Objective: Cameroon, located in Central Africa, is characterized by a high endemicity of hepatitis B. National studies estimate the prevalence of HBs antigen carriage to range between 8% and 15% in the general population. Identified high-risk groups include adolescents and young adults, among whom university students represent a vulnerable population. The objective of this study was to assess the seroprevalence of hepatitis B viral biomarkers among students at the University of Yaoundé II in Cameroon. Methods: We conducted a cross-sectional analytical study from February 20 to June 20, 2024. Samples were collected at the Soa campus of the University of Yaoundé II. Initial testing was performed using rapid diagnostic tests at the university, followed by ELISA (Fortress Diagnostics) at the blood bank of the Central Hospital of Yaoundé. The detection of anti-HBs, HBe antigen (HBeAg), anti-HBe, and anti-HBc was carried out using the Hightop HBV 5-in-1 rapid test. Data were processed and analyzed using Microsoft Excel 2019 and SPSS Version 25. The chi-square test, Fisher's exact test, and odds ratio calculations for comparing proportions and logistic regression were used to search for risk factors. The result was significant with a Results: A total of 250 students were tested. HBs antigen was positive in eight students (3.2%). Among these, anti-HBs and HBeAg were absent, while anti-HBe was positive in six out of eight (75.0%) and anti-HBc was positive in all eight cases (100%). Only two students (0.8%) had been vaccinated against hepatitis B. Conclusion: All eight HBsAg-positive students were in the chronic phase of hepatitis B infection. A history of blood transfusion and unprotected sexual intercourse was strongly associated with HBV infection. Vaccination coverage was extremely low, highlighting the need for targeted immunization programs in this population. Educational and awareness efforts regarding transmission routes and preventive measures must be strengthened.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.